Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Diversity of heart failure phenotypes in transthyretin amyloid cardiomyopathy. More than just heart failure with preserved ejection fraction.

Annals of medicine - 1 Dec 2024

Achten Anouk, Muller Steven A, Wijk Sandra Sanders-van, van der Meer Manon G, van der Harst Pim, van Tintelen Peter, Te Riele Anneline Sjm, van Empel Vanessa, Oerlemans Marish Ifj, Knackstedt Christian

Abstract excerpt

INTRODUCTION: Current guidelines recommend suspecting transthyretin amyloid cardiomyopathy (ATTR-CM) in patients over 65 years of age with unexplained left ventricular (LV) hypertrophy in a non-dilated LV, heart failure (HF) and preserved ejection fraction (HFpEF), hypertrophic cardiomyopathy or severe aortic stenosis. However, there is evidence indicating a high prevalence of ATTR-CM in other HF phenotypes. As...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Amyloid Neuropathies, Familial

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cardiomyopathies

Share to Echocardiography

Share to Heart Failure

Share to Hypertrophy, Left Ventricular

Share to Stroke Volume

Share to Ventricular Function, Left

Source

Open in PubMed Open full text

Identifiers

PMID: 39460551
DOI: 10.1080/07853890.2024.2418965
PMCID: PMC11514392

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Diversity of heart failure phenotypes in transthyretin amyloid cardiomyopathy. More than just heart failure with preserved ejection fraction.PMID 39460551Read ↗

Transthyretin cardiac amyloid: Broad heart failure phenotypic spectrum and implications for diagnosis.Semantic proximity Read ↗

Diagnostic Pitfall and Clinical Characteristics of Variant Versus Wild-Type Transthyretin Amyloid Cardiomyopathy in Asian Population: The Korean Nationwide Cohort Study.Semantic proximity Read ↗

Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction.Semantic proximity Read ↗

Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From the American Heart Association.Semantic proximity Read ↗

Pilot study for left ventricular imaging phenotype of patients over 65 years old with heart failure and preserved ejection fraction: the high prevalence of amyloid cardiomyopathy.Semantic proximity Read ↗

Echocardiographic phenotype and prognosis in transthyretin cardiac amyloidosis.Semantic proximity Read ↗

Transthyretin cardiac amyloidosis in continental Western Europe: an insight through the Transthyretin Amyloidosis Outcomes Survey (THAOS)Semantic proximity Read ↗

Transthyretin Amyloid Cardiomyopathy–2025 Update: Current Diagnostic Approaches and Emerging Therapeutic OptionsSemantic proximity Read ↗

Transthyretin amyloid cardiomyopathy in patients with unexplained increased left ventricular wall thickness.Semantic proximity Read ↗

Transthyretin amyloidosis cardiomyopathy in Greece: Clinical insights from the National Referral Center.Semantic proximity Read ↗

Clinical and imaging profiling of restrictive cardiomyopathies: insights into amyloid, sarcoid, and iron overload phenotypes.Semantic proximity Read ↗

[Hypertrophic cardiomyopathies and ATTR amyloidosis - a current review for clinical practice].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.